WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011015537) CO-THERAPY FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/015537    International Application No.:    PCT/EP2010/061157
Publication Date: 10.02.2011 International Filing Date: 30.07.2010
IPC:
A61K 31/401 (2006.01), A61K 31/00 (2006.01), A61P 25/08 (2006.01)
Applicants: CONVERGENCE PHARMACEUTICALS LIMITED [--/GB]; 90 High Holborn London WC1V 6XX (GB) (For All Designated States Except US).
ALVARO, Giuseppe [IT/IT]; (IT) (For US Only).
LARGE, Charles [GB/IT]; (IT) (For US Only)
Inventors: ALVARO, Giuseppe; (IT).
LARGE, Charles; (IT)
Agent: GIBSON, Mark; Sagittarius IP Taylor House 39 High Street Marlow Buckinghamshire SL7 1AF (GB)
Priority Data:
61/231,498 05.08.2009 US
Title (EN) CO-THERAPY FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
(FR) CO-THÉRAPIE POUR LE TRAITEMENT DE L'ÉPILEPSIE ET DES TROUBLES ASSOCIÉS
Abstract: front page image
(EN)The present invention relates to co-therapy for the treatment of epilepsy and related disorders comprising administering to a subject in need thereof, co-therapy with a therapeutically effective amount of 5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)- prolinamide, or a pharmaceutically acceptable salt or solvate thereof, and a therapeutically effective amount of one or more anticonvulsant and / or anti-epileptic agents.
(FR)La présente invention concerne la co-thérapie pour le traitement de l'épilepsie et des troubles associés. Ladite co-thérapie comporte l'administration, à un sujet en ayant besoin, d'une co-thérapie avec une quantité thérapeutique efficace de 5-(4-{[(2-fluorophényl)méthyl]oxy}phényl)-prolinamide, ou d'un sel ou d'un solvate de qualité pharmaceutique de celui-ci, et une quantité thérapeutique efficace d'un ou de plusieurs agents anti-convulsifs et/ou anti-épileptiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)